Related Experiment Videos
[Mitral valve replacement in children with a Björk-Shiley prosthesis]
Archivos Del Instituto De Cardiologia De Mexico
|November 1, 1984
Summary
Mitral valve replacement in children using the Björk-Shiley prosthesis showed a 79% 5-year survival rate. This procedure offers excellent outcomes for pediatric patients with severe heart conditions when valve repair is not feasible.
Area of Science:
- Pediatric Cardiology
- Cardiac Surgery
- Biomaterials Science
Context:
- Mitral valve disease in children presents unique challenges.
- Surgical interventions are critical for improving pediatric cardiac function.
- Limited data exists on long-term outcomes of specific prostheses in pediatric populations.
Purpose:
- To document the experience and outcomes of mitral valve replacement in pediatric patients.
- To evaluate the efficacy and safety of the Björk-Shiley prosthesis in children.
- To assess functional capacity and survival rates post-operation.
Summary:
- 30 pediatric patients (<15 years) underwent mitral valve replacement (1978-1982) for rheumatic (90%) or congenital (10%) heart disease.
- Preoperative functional capacity was significantly impaired (NYHA Class II-IV).
- Early mortality was 3.3%, with a 5-year actuarial survival of 79%. Postoperative functional class improved significantly (NYHA Class I-II).
Impact:
- The Björk-Shiley prosthesis demonstrates favorable long-term results in pediatric mitral valve replacement.
- This study provides valuable data for surgical decision-making in complex pediatric cardiac cases.
- Improved functional capacity and survival rates highlight the benefits of timely intervention.